Literature DB >> 26137106

Integrated analysis of differentially expressed genes in breast cancer pathogenesis.

Daobao Chen1, Hongjian Yang1.   

Abstract

The present study aimed to detect the differences between breast cancer cells and normal breast cells, and investigate the potential pathogenetic mechanisms of breast cancer. The sample GSE9574 series was downloaded, and the microarray data was analyzed to identify differentially expressed genes (DEGs). Gene Ontology (GO) cluster analysis using the GO Enrichment Analysis Software Toolkit platform and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for DEGs was conducted using the Gene Set Analysis Toolkit V2. In addition, a protein-protein interaction (PPI) network was constructed, and target sites of potential transcription factors and potential microRNA (miRNA) molecules were screened. A total of 106 DEGs were identified in the current study. Based on these DEGs, a number of bio-pathways appear to be altered in breast cancer, including a number of signaling pathways and other disease-associated pathways, as indicated by KEGG pathway clustering analysis. ATF3, JUND, FOSB and JUNB were detected in the PPI network. Finally, the most significant potential target sites of transcription factors and miRNAs in breast cancer, which are important in the regulation of gene expression, were identified. The results indicated that miR-93, miR-302A, miR-302B, miR-302C, miR-302D, miR-372, miR-373, miR-520E and miR-520A were closely associated with the occurrence and development of breast cancer. Therefore, changes in the expression of these miRNAs may alter cell metabolism and trigger the development of breast cancer and its complications.

Entities:  

Keywords:  breast cancer; differentially expressed genes; function and pathway annotation; microRNA; protein-protein interaction network; transcription factors

Year:  2015        PMID: 26137106      PMCID: PMC4473354          DOI: 10.3892/ol.2015.3147

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

Review 1.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

2.  Breast cancer in the young patient.

Authors:  Jack Sariego
Journal:  Am Surg       Date:  2010-12       Impact factor: 0.688

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe.

Authors:  Milena Sant; Claudia Allemani; Riccardo Capocaccia; Timo Hakulinen; Tiiu Aareleid; Jan Willem Coebergh; Michel P Coleman; Pascale Grosclaude; Carmen Martinez; Janine Bell; Judith Youngson; Franco Berrino
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

5.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

6.  MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells.

Authors:  Steven J Greco; Pranela Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-13       Impact factor: 11.205

7.  Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients.

Authors:  Anusri Tripathi; Chialin King; Antonio de la Morenas; Victoria Kristina Perry; Bohdana Burke; Gregory A Antoine; Erwin F Hirsch; Maureen Kavanah; Jane Mendez; Michael Stone; Norman P Gerry; Marc E Lenburg; Carol L Rosenberg
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396

8.  The molecular portraits of breast tumors are conserved across microarray platforms.

Authors:  Zhiyuan Hu; Cheng Fan; Daniel S Oh; J S Marron; Xiaping He; Bahjat F Qaqish; Chad Livasy; Lisa A Carey; Evangeline Reynolds; Lynn Dressler; Andrew Nobel; Joel Parker; Matthew G Ewend; Lynda R Sawyer; Junyuan Wu; Yudong Liu; Rita Nanda; Maria Tretiakova; Alejandra Ruiz Orrico; Donna Dreher; Juan P Palazzo; Laurent Perreard; Edward Nelson; Mary Mone; Heidi Hansen; Michael Mullins; John F Quackenbush; Matthew J Ellis; Olufunmilayo I Olopade; Philip S Bernard; Charles M Perou
Journal:  BMC Genomics       Date:  2006-04-27       Impact factor: 3.969

9.  Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma.

Authors:  Ilhem Diboun; Lorenz Wernisch; Christine Anne Orengo; Martin Koltzenburg
Journal:  BMC Genomics       Date:  2006-10-09       Impact factor: 3.969

10.  GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis.

Authors:  Qi Zheng; Xiu-Jie Wang
Journal:  Nucleic Acids Res       Date:  2008-05-16       Impact factor: 16.971

View more
  10 in total

1.  Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.

Authors:  He Li; Heping Xiang; Weiwei Ge; Hengtong Wang; Tianpeng Wang; Maoming Xiong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.

Authors:  Md Nazim Uddin; Xiaosheng Wang
Journal:  Breast Cancer       Date:  2022-01-12       Impact factor: 3.307

3.  The decreased expression of hsa_circ_0043278 and its relationship with clinicopathological features of breast cancer.

Authors:  Chong Liu; Tao Han; Yue Shi
Journal:  Gland Surg       Date:  2020-12

4.  Downregulation of hsa_circ_0006220 and its correlation with clinicopathological factors in human breast cancer.

Authors:  Chong Liu; Mingshi Chen; Yue Shi
Journal:  Gland Surg       Date:  2021-02

5.  miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.

Authors:  Alessandra Cataldo; Douglas G Cheung; Andrea Balsari; Elda Tagliabue; Vincenzo Coppola; Marilena V Iorio; Dario Palmieri; Carlo M Croce
Journal:  Oncotarget       Date:  2016-01-05

6.  Identification of common key genes in breast, lung and prostate cancer and exploration of their heterogeneous expression.

Authors:  Richa K Makhijani; Shital A Raut; Hemant J Purohit
Journal:  Oncol Lett       Date:  2017-11-30       Impact factor: 2.967

7.  HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.

Authors:  Carolyn M Klinge; Kellianne M Piell; Christine Schaner Tooley; Eric C Rouchka
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

8.  CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer.

Authors:  Quan Liang; Qingjuan Yao; GuoYing Hu
Journal:  Open Med (Wars)       Date:  2019-12-04

9.  miR‑302d‑3p regulates the viability, migration and apoptosis of breast cancer cells through regulating the TMBIM6‑mediated ERK signaling pathway.

Authors:  Yanru Liao; Zhenxiong Qiu; Ling Bai
Journal:  Mol Med Rep       Date:  2021-10-15       Impact factor: 2.952

10.  Fold change based approach for identification of significant network markers in breast, lung and prostate cancer.

Authors:  Richa K Makhijani; Shital A Raut; Hemant J Purohit
Journal:  IET Syst Biol       Date:  2018-10       Impact factor: 1.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.